Women Speakers Database
Photo
-
Name
Jianli Wang -
Email
jlwang@zju.edu.cn -
Country/Region
China -
Institute
Zhejiang University -
Career Stage
Tenured Faculty -
Website
https://person.zju.edu.cn/0001010 -
Research Interests
-
Profile
Jianli Wang is Director of Department of Immunology; Professor and doctoral supervisor of Institute of Immunology, Zhejiang University. Her main research fields focus on basic and clinical therapeutic research of tumor by immune and genic method. She is the first domestic one who explored novel tumor vaccine through fusion of dendritic cells and tumor cells. She also carried out the research about utilizing exosomes from tumor and dendritic cells as novel tumor vaccine. She had published more than 70 papers in professional magazine and some of these had reached advanced international standards. As the first proposer, she had applied for 12 items of the national patent of invention and been authorized 10 items. She had presided and carried out research of immunotherapy based on dendritic cells and founded the national technical standard about treatment of malignancy by dendritic cells. This project had been approved by SFDA and completed clinical phase II research. The application of clinical phase III had been submitted to SFDA. At the same time, she served as associate editor of the Journal of International Immunology, and as editorial board of the Cellular & Molecular Immunology, and so on. She acquired more than 10 grants, including the National Basic Research Program(973 Program) , National High Technology Research and Development Program(863 Program), National Nature Science Foundation, Nature Science Foundation of Zhejiang Province.